| Cover | Feb. 14, 2024 |
| Entity Addresses [Line Items] | |
| Document Type | 8-K |
| Document Period End Date | Feb. 14, 2024 |
| Entity Registrant Name | Summit Therapeutics Inc. |
| Entity Incorporation, State or Country Code | DE |
| Entity File Number | 001-36866 |
| Entity Tax Identification Number | 37-1979717 |
| Entity Address, Address Line One | 601 Brickell Key Drive, Suite 1000 |
| Entity Address, City or Town | Miami |
| Entity Address, State or Province | FL |
| Entity Address, Postal Zip Code | 33131 |
| City Area Code | (650) |
| Local Phone Number | 460-8308 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common stock, $0.01 par value per share |
| Trading Symbol | SMMT |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | false |
| Entity Central Index Key | 0001599298 |
| Amendment Flag | false |
